Opinion
Video
Expert on Aquablation’s comparable long-term outcomes in prostates of different sizes
Author(s):
Key Takeaways
- Aquablation therapy offers precision in BPH treatment, achieving millimeter-level accuracy and reducing adverse events.
- Robotic assistance in Aquablation ensures reproducibility and eliminates the learning curve, contributing to consistent outcomes.
"I think [for] the consistency, we can give [a lot of] credit to the fact that Aquablation gives a lot of precision in terms of treating BPH," says Mohamad Baker Berjaoui, MD.
In this video, Mohamad Baker Berjaoui, MD, discusses the finding from the BJUI Compass paper, “WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80-cm3 and 80–150-cm3 prostates” that Aquablation had comparable long-term outcomes for prostates of different sizes. Berjaoui is a urology resident at the University of Toronto in Ontario, Canada.
Transcription:
Given the study's findings, how do you explain the comparable long-term outcomes for Aquablation in prostates of different sizes? Are there any specific factors or mechanisms that contribute to this consistency?
I think [for] the consistency, we can give [a lot of] credit to the fact that Aquablation gives a lot of precision in terms of treating BPH. The fact that it's robotically induced gives the surgeon the ability to go after the prostate in a lot of precision, up to like millimeters of precision, and that definitely improves the results, and it minimizes, on the opposite side, the [adverse events]. Also, it's very reproducible. There's no learning curve, and I think the lack of thermal injury by laser or electrocautery also helps significantly [in]minimizing the [adverse events] and improving the results.
This transcript was AI generated and edited by human editors for clarity.
